Presentations at the public Inno-HTA Dissemination Workshop
"Inno-HTA: Adding value to comprehensive early assessment of health care innovations
from a public and private perspective"
4th of December 2008, Hotel Admiral, Copenhagen
Invitation and programme
Finn Børlum Kristensen. National Board of Health, Project leader European Network for HTA – EunetHTA, Adjunct Professor, University of Southern Denmark
Constructive assessment of emerging technologies: bridging the gap between innovation and regulation
Arie Rip. Professor of Philosophy of Science and Technology in the School of Management and Governance of the University of Twente, The Netherlands
Results of Inno-HTA
Bernhard Buehrlen, Coordinator Inno-HTA project, Fraunhofer Institute
EUnetHTA Common Core HTA and Added value of Inno-HTA in relation to ‘classic’ HTA
Kristian Lampe, Senior Medical Officer, FinOHTA, project leader of EunetHTA WP4 on developing a core model for HTA
Added value of Inno-HTA for producers/manufacturers’ R&D decision-making
Richard Bergström, Vice-chair of EFPIA’s (The European Federation of Pharmaceutical Industries and Assocations) HTA Working Group, Director-General of LIF, The Swedish Association of the Pharmaceutical Industry.
Added value of Inno-HTA for consumers/patients
Cees Smit, The Dutch Genetic Alliance (VSOP), Honorary member of Epposi, The European Platform for Patients' Organisations, Science and Industry.
Added value of Inno-HTA to support national and European R&D policy
Fabian Waechter, former at Austrian Agency for Health and Food Safety (AGES)